One biologic marker (carbohydrate antigen- CA 125), two different diseases (ovarian cancer and congestive heart failure): Practical implications of monitoring CA 125 serum levels. A case report

Italian Heart Journal

Volumn 4, Issue 7, 2003, Pages 497-499

  Faggiano, Pompilio ^a   D'Aloia, Antonio ^a   Bignotti, Tommaso ^a   Cas, Livio Dei ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Atrial natriuretic factor; Congestive heart failure; Immunological system

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ARTICLE; BLOOD; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MIDDLE AGED; MONITORING; OVARY TUMOR; RECURRENT DISEASE;

CA-125 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OVARIAN NEOPLASMS; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 1542390541     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Bast RC Jr, Klug TL, John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309: 883-7.
2. O'Brien TJ, Tanimoto H, Konishi I, Gee M. More than 15 years of CA 125: what is known about the antigen, its structure and its function. Int J Biol Markers 1998; 13: 188-95.
3. Nagele H, Bahlo M, Klapdor R, Schaeperkoetter D, Rodiger W. CA 125 and its relation to cardiac function. Am Heart J 1999; 137: 1044-9.
4. D'Aloia A, Faggiano P, Aurigemma G, et al. Serum levels of CA 125 in patients with chronic heart failure. Relation to clinical seventy, hemodynamic and Doppler echocardiographic abnormalities and short-term prognosis. J Am Coll Cardiol 2003; 41: 1805-11.